Literature DB >> 12878741

Acquired von Willebrand syndrome in aortic stenosis.

André Vincentelli1, Sophie Susen, Thierry Le Tourneau, Isabelle Six, Olivier Fabre, Francis Juthier, Anne Bauters, Christophe Decoene, Jenny Goudemand, Alain Prat, Brigitte Jude.   

Abstract

BACKGROUND: Aortic-valve stenosis can be complicated by bleeding that is associated with acquired type 2A von Willebrand syndrome. However, the prevalence and cause of the hemostatic abnormality in aortic stenosis are unknown.
METHODS: We enrolled 50 consecutive patients with aortic stenosis, who completed a standardized screening questionnaire to detect a history of bleeding. Forty-two patients with severe aortic stenosis underwent valve replacement. Platelet function under conditions of high shear stress, von Willebrand factor collagen-binding activity and antigen levels, and the multimeric structure of von Willebrand factor were assessed at base line and one day, seven days, and six months postoperatively.
RESULTS: Skin or mucosal bleeding occurred in 21 percent of the patients with severe aortic stenosis. Platelet-function abnormalities under conditions of high shear stress, decreased von Willebrand factor collagen-binding activity and the loss of the largest multimers, or a combination of these was present in 67 to 92 percent of patients with severe aortic stenosis and correlated significantly with the severity of valve stenosis. Primary hemostatic abnormalities were completely corrected on the first day after surgery but tended to recur at six months, especially when there was a mismatch between patient and prosthesis (with an effective orifice area of less than 0.8 cm2 per square meter of body-surface area).
CONCLUSIONS: Type 2A von Willebrand syndrome is common in patients with severe aortic stenosis. Von Willebrand factor abnormalities are directly related to the severity of aortic stenosis and are improved by valve replacement in the absence of mismatch between patient and prosthesis. Copyright 2003 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878741     DOI: 10.1056/NEJMoa022831

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  150 in total

1.  Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation.

Authors:  Joanna Luszczak; Anetta Undas; Matthew Gissel; Maria Olszowska; Saulius Butenas
Journal:  Blood Coagul Fibrinolysis       Date:  2011-09       Impact factor: 1.276

Review 2.  Physiologic and pathologic changes in patients with continuous-flow ventricular assist devices.

Authors:  Ranjit John; Andrew Boyle; Frank Pagani; Leslie Miller
Journal:  J Cardiovasc Transl Res       Date:  2009-03-04       Impact factor: 4.132

3.  Our findings differ.

Authors:  Giuseppe Famularo; Laura Gasbarrone; Giovanni Minisola
Journal:  CMAJ       Date:  2015-10-20       Impact factor: 8.262

4.  Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Cui Jian; Juan Xiao; Lingjie Gong; Christopher G Skipwith; Sheng-Yu Jin; Hau C Kwaan; X Long Zheng
Journal:  Blood       Date:  2012-01-30       Impact factor: 22.113

5.  Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis.

Authors:  Rihab Bouchareb; Marie-Chloé Boulanger; Lionel Tastet; Ghada Mkannez; Mohamed J Nsaibia; Fayez Hadji; Abdellaziz Dahou; Younes Messadeq; Benoit J Arsenault; Philippe Pibarot; Yohan Bossé; André Marette; Patrick Mathieu
Journal:  Eur Heart J       Date:  2019-05-01       Impact factor: 29.983

Review 6.  Prosthesis-patient mismatch: definition, clinical impact, and prevention.

Authors:  P Pibarot; J G Dumesnil
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

7.  Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Authors:  E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee
Journal:  Haemophilia       Date:  2013-03       Impact factor: 4.287

Review 8.  Gastrointestinal Bleeding in Native and Prosthetic Valve Disease.

Authors:  Joseph L Blackshear
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-03

9.  Timing of surgery in aortic stenosis.

Authors:  Siva B Mohan; George A Stouffer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

Review 10.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.